MULTAQ DIN 02330989
Status: Marketed
Holder: SANOFI-AVENTIS CANADA INC
Molecule: DRONEDARONE (DRONEDARONE HYDROCHLORIDE)
Available to quote
Health Canada record
| Active ingredient(s) | DRONEDARONE (DRONEDARONE HYDROCHLORIDE) 400 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C01BD07 DRONEDARONE |
| Original market date | 28-Sep-2009 |
| Current status date | 28-Sep-2009 |
| Source | Health Canada DPD |
Establishment licence of the holder
sanofi-aventis Canada Inc. — licence 101470, currently licensed, last inspection rating C (2026-02-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DRONEDARONE (DRONEDARONE HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02514397 | ASN-DRONEDARONE | ASCEND LABORATORIES LTD | Tablet | DRONEDARONE (DRONEDARONE HYDROCHLORIDE) 400 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10495 | 2009-08-11 | New Drug Submission (NDS) |